CClinicalTrials.gg
RecruitingNCT06744218Updated Dec 26, 2025

Effectiveness of Telerehabilitation as an Alternative to Outpatient Physiotherapy in the 1 Month After Arthroscopic Rotator Cuff Repair Surgery

An interventional study of Standard Treatment and Experimental Treatment in Rotator Cuff Injuries, sponsored by Istituto Ortopedico Rizzoli. Recruiting at 2 sites in Italy. Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-12-26.

Sponsored by Istituto Ortopedico Rizzoli · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Nov 2024; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
40 Years to 70 Years
Sex
All
01

Study summary

The present study aims to verify whether telerehabilitation as an alternative to in-person treatment (both conducted by a physiotherapist) can be a valid option in terms of pain, recovery of the rom, shoulder functionality compared to those provided by therapy alone. face-to-face rehabilitation in patients undergoing arthroscopic rotator cuff repair surgery.

02

Conditions studied

  • Rotator Cuff Injuries

Browse trials for

Keywords

  • telerehabilitation
  • physiotherapist
  • rotator cuff repair surgery
03

In context

Rotator Cuff Injuries

734 studies on the registry are indexed under Rotator Cuff Injuries; 161 are open to participants now.

This study's planned enrollment of 46 is below the median of 60 across 538 interventional studies indexed under Rotator Cuff Injuries.

Browse Rotator Cuff Injuries studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 298 studies on the registry; 102 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Male or female patients aged between 40 and 70 years
  • Patients undergoing arthroscopic repair surgery of the rotator cuff tendons
  • Start of outpatient treatment within 7 days of discharge from the Orthopedic Department of the Argenta and Delta hospitals
  • Continuation of rehabilitation care at the IOR Physical and Rehabilitation Medicine service in Argenta or at the Physical Therapy Rehabilitation Medicine service of the Delta Hospital.
  • Patients who have provided informed consent

Exclusion criteria

Exclusion Criteria:

  • Previous shoulder surgeries
  • difficulty understanding the Italian language/language barrier
  • unavailability of IT devices or stable wi-fi connection by the patient
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
46 participants (estimated)

Study arms

  • Active comparator
    Standard

    Procedure: Standard Treatment

  • Experimental
    experimental

    Procedure: Experimental Treatment

Interventions

  • ProcedureStandard Treatment

    Patients who will be assigned to the control group and subjected to standard treatment (usual care at our clinic) will undergo a physiotherapy treatment of 8 in-person sessions for 4 post-operative weeks

  • ProcedureExperimental Treatment

    patients who will be assigned to the experimental group and subjected to the experimental treatment will undergo a physiotherapy treatment of 8 sessions in telerehabilitation for 4 post-operative weeks

06

What researchers measure

Primary outcomes

  1. Constant-Murley Score

    The Constant-Murley score (CMS) is a 100-point scale made up of a series of individual parameters. These parameters define the patient's pain level and ability to carry out normal daily activities

    Time frame: At baseline (day 0), after one months, after 3 months

Secondary outcomes

  1. Mobility of the shoulder

    Range of motion of the shoulder seen by movements made during the rehabilitation

    Time frame: At baseline (day 0), after one months, after 3 months

  2. Numeric rating scale

    Description of pain by numeric rating scale, from 0 no pain, to 10 worst pain ever (0-10)

    Time frame: At baseline (day 0), after one months, after 3 months

  3. Disabilities of the Arm, Shoulder and Hand

    The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that examines a patient's ability to perform certain upper extremity activities

    Time frame: at baseline, after 3 months and after 6 months

07

Study locations

1 of 2 sites recruiting
  • Ospedale del Delta
    Lagosanto, Ferrara 44023, Italy
    • elisabetta zucchini · Contact
    Not yet recruiting
  • IRCCS Istituto ortopedico Rizzoli
    Bologna, Italia 40136, Italy
    • Silvana Sartini, MD · Contact · 0516366
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06744218
Lead sponsor
Istituto Ortopedico Rizzoli
Responsible party
Sponsor
First posted
Dec 20, 2024
Start date
Nov 22, 2024
Primary completion
Oct 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Dec 26, 2025

Study contacts

Silvana Sartini, MD
Contact
silvana.sartini@ior.it
0516366 ext. 051

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion